Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 410

1.

Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.

Padula MC, Leccese P, Pellizzieri E, Padula AA, Gilio M, Carbone T, Lascaro N, Tramontano G, Martelli G, D'Angelo S.

Intern Emerg Med. 2019 Feb 28. doi: 10.1007/s11739-019-02056-w. [Epub ahead of print]

PMID:
30820838
2.

Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration.

Parmeggiani F, Gallenga CE, Costagliola C, Semeraro F, Romano MR, Dell'Omo R, Russo A, De Nadai K, Gemmati D, D'Angelo S, Bolletta E, Sorrentino FS.

Sci Rep. 2019 Feb 22;9(1):2614. doi: 10.1038/s41598-019-38919-7.

3.

Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.

Carbone T, Pafundi V, Tramontano G, Gilio M, Padula MC, Padula AA, D'Angelo S.

Sci Rep. 2019 Feb 18;9(1):2177. doi: 10.1038/s41598-019-38686-5.

4.

Deep Anterior Lamellar Keratoplasty in Eyes With Intrastromal Corneal Ring Segments.

Ravera V, Bovone C, Scorcia V, DʼAngelo S, Busin M.

Cornea. 2019 Feb 12. doi: 10.1097/ICO.0000000000001906. [Epub ahead of print]

PMID:
30768438
5.

Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach.

Padula MC, Leccese P, Lascaro N, Carbone T, Gilio M, Padula AA, Martelli G, D'Angelo S.

Hum Immunol. 2019 Feb 8. pii: S0198-8859(18)30941-8. doi: 10.1016/j.humimm.2019.02.003. [Epub ahead of print]

PMID:
30742879
6.

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma.

D'Angelo SP, Hunger M, Brohl AS, Nghiem P, Bhatia S, Hamid O, Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, Linette GP, Milella M, Schlichting M, Hennessy MH, Bharmal M.

Cancer Immunol Immunother. 2019 Feb 5. doi: 10.1007/s00262-018-02295-4. [Epub ahead of print]

PMID:
30721341
7.

Avelumab Immunotherapy: Management of Adverse Events Associated With New Treatment for Merkel Cell Carcinoma.

Ugolini H, Bryan J, Hennessy M, Kaufman HL, D'Angelo S.

Clin J Oncol Nurs. 2019 Feb 1;23(1):E1-E9. doi: 10.1188/19.CJON.E1-E9.

PMID:
30682006
8.

The need for comparative data in spondyloarthritis.

Choy E, Baraliakos X, Behrens F, D'Angelo S, de Vlam K, Kirkham BW, Østergaard M, Schett GA, Rissler M, Chaouche-Teyara K, Perella C.

Arthritis Res Ther. 2019 Jan 22;21(1):32. doi: 10.1186/s13075-019-1812-3.

9.

The Effect of Vitamin D Supplementation on Hepcidin, Iron Status, and Inflammation in Pregnant Women in the United Kingdom.

Braithwaite VS, Crozier SR, D'Angelo S, Prentice A, Cooper C, Harvey NC, Jones KS; MAVIDOS Trial Group.

Nutrients. 2019 Jan 18;11(1). pii: E190. doi: 10.3390/nu11010190.

10.

Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT.

Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038/s41588-018-0312-8. Epub 2019 Jan 14.

PMID:
30643254
11.

BPA and nutraceuticals, simultaneous effects on endocrine functions.

D'Angelo S, Scafuro M, Meccariello R.

Endocr Metab Immune Disord Drug Targets. 2019 Jan 1. doi: 10.2174/1871530319666190101120119. [Epub ahead of print]

PMID:
30621569
12.

Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study.

D'Angelo S, Chiaravalloti A, Ursini F, Barbagallo G, Gilio M, Leccese P, De Giorgio R, Di Giorgio E, Schillaci O.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):148-149. Epub 2018 Dec 14. No abstract available.

13.

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Andreoli L, Lazzaroni MG, Carini C, Dall'Ara F, Nalli C, Reggia R, Rodrigues M, Benigno C, Baldissera E, Bartoloni-Bocci E, Basta F, Bellisai F, Bortoluzzi A, Campochiaro C, Cantatore FP, Caporali R, Ceribelli A, Chighizola CB, Conigliaro P, Corrado A, Cutolo M, D'Angelo S, De Stefani E, Doria A, Favaro M, Fischetti C, Foti R, Gabrielli A, Generali E, Gerli R, Gerosa M, Larosa M, Maier A, Malavolta N, Meroni M, Meroni PL, Montecucco C, Mosca M, Padovan M, Paolazzi G, Pazzola G, Peccatori S, Perricone R, Pettiti G, Picerno V, Prevete I, Ramoni V, Romeo N, Ruffatti A, Salvarani C, Sebastiani GD, Selmi C, Serale F, Sinigaglia L, Tani C, Trevisani M, Vadacca M, Valentini E, Valesini G, Visalli E, Vivaldelli E, Zuliani L, Tincani A.

Joint Bone Spine. 2018 Dec 21. pii: S1297-319X(18)30257-4. doi: 10.1016/j.jbspin.2018.12.002. [Epub ahead of print]

PMID:
30579917
14.

Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies.

Andreoli L, Gerardi MC, Fernandes M, Bortoluzzi A, Bellando-Randone S, Brucato A, Caporali R, Chighizola CB, Chimenti MS, Conigliaro P, Cutolo M, Cutro MS, D'Angelo S, Doria A, Elefante E, Fredi M, Galeazzi M, Gerosa M, Govoni M, Iuliano A, Larosa M, Lazzaroni MG, Matucci-Cerinic M, Meroni M, Meroni PL, Mosca M, Patanè M, Pazzola G, Pendolino M, Perricone R, Ramoni V, Salvarani C, Sebastiani GD, Selmi C, Spinelli FR, Valesini G, Scirè CA, Tincani A.

Autoimmun Rev. 2019 Feb;18(2):164-176. doi: 10.1016/j.autrev.2018.08.008. Epub 2018 Dec 18. Review.

PMID:
30572134
15.

Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement.

Marchesoni A, D'Angelo S, Anzidei M, Bortolotti R, Cantini F, Caramella D, Carotti M, Chimenti MS, Delle Sedie A, Egan CG, Fabbroni M, Frediani B, Fusaro E, Galeazzi M, Gallazzi MB, Gentileschi S, Gentili F, Gerli R, Gilio M, Iannone F, La Paglia E, Lubrano E, Macarini L, Olivieri I, Pellerito R, Ramonda R, Salvarani C, Scarano E, Scarpa R, Spaggiari L, Spanò A, Zawaideh JP, Mazzei MA; SHARE Study Group.

Clin Exp Rheumatol. 2018 Nov 16. [Epub ahead of print]

PMID:
30557127
16.

Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.

Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.

Autoimmun Rev. 2019 Jan;18(1):93-106. doi: 10.1016/j.autrev.2018.08.003. Epub 2018 Nov 5. Review.

PMID:
30408582
17.

Prevalence of and risk factors for gout in HIV-positive adults: A case-control study.

Nicholson P, Saunsbury E, D'Angelo S, Churchill D, Walker-Bone K.

Int J STD AIDS. 2019 Mar;30(3):249-255. doi: 10.1177/0956462418799803. Epub 2018 Nov 4.

PMID:
30392464
18.

Gestational Vitamin D Supplementation Leads to Reduced Perinatal RXRA DNA Methylation: Results From the MAVIDOS Trial.

Curtis EM, Krstic N, Cook E, D'Angelo S, Crozier SR, Moon RJ, Murray R, Garratt E, Costello P, Cleal J, Ashley B, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Prentice A, Javaid MK, Inskip HM, Godfrey KM, Bell CG, Lillycrop KA, Cooper C, Harvey NC; MAVIDOS Trial Group.

J Bone Miner Res. 2019 Feb;34(2):231-240. doi: 10.1002/jbmr.3603. Epub 2019 Jan 18.

19.

Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus.

Bortoluzzi A, Valesini G, D'Angelo S, Frediani B, Bazzichi L, Afeltra A, Paolazzi G, Doria A, Meroni PL, Govoni M.

Rheumatology (Oxford). 2018 Oct 1;57(57 Suppl 7):vii32-vii41. doi: 10.1093/rheumatology/key076. Review.

PMID:
30289538
20.

Job stress and post-retirement health in the Hertfordshire Cohort Study.

Walker-Bone K, D'Angelo S, Stevens M, Linaker C, Dennison E, Cooper C, Syddall H.

Occup Med (Lond). 2018 Dec 26;68(9):572-579. doi: 10.1093/occmed/kqy123.

PMID:
30265338
21.

Arthritis Mutilans in Systemic Sclerosis.

Abignano G, Mennillo GA, Lettieri G, Padula A, McGonagle D, D'Angelo S.

Arthritis Rheumatol. 2019 Jan;71(1):120. doi: 10.1002/art.40723. Epub 2018 Nov 24. No abstract available.

PMID:
30221850
22.

A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor.

Kelly CM, Shoushtari AN, Qin LX, D'Angelo SP, Dickson MA, Gounder MM, Keohan ML, Mcfadyen C, Sjoberg A, Singer S, DeMatteo RP, Hwang S, Heinemann MH, Francis JH, Antonescu CR, Chi P, Tap WD.

Invest New Drugs. 2018 Aug 13. doi: 10.1007/s10637-018-0648-z. [Epub ahead of print]

PMID:
30101387
23.

Comments on "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".

Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.

J Am Acad Dermatol. 2018 Dec;79(6):e119-e120. doi: 10.1016/j.jaad.2018.07.052. Epub 2018 Aug 7. No abstract available.

PMID:
30096421
24.

New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Santarsiero A, Leccese P, Convertini P, Padula A, Abriola P, D'Angelo S, Bisaccia F, Infantino V.

Mediators Inflamm. 2018 Jun 28;2018:1419352. doi: 10.1155/2018/1419352. eCollection 2018.

25.

Diffuse Idiopathic Skeletal Hyperostosis in an HLA-B27-Positive Subject.

Gilio M, Scarano E, Padula A, Tramontano G, DʼAngelo S, Olivieri I.

J Clin Rheumatol. 2018 Jul 25. doi: 10.1097/RHU.0000000000000865. [Epub ahead of print] No abstract available.

PMID:
30048388
26.

Comparison of lente insulin and NPH insulin therapy for the treatment of newly diagnosed diabetic dogs: a randomised study.

Fracassi F, Linari G, Del Baldo F, Di Cunzolo A, D'Angelo S, Malerba E, Carotenuto G, Bonfanti U, Corradini S.

Vet Rec. 2018 Sep 1;183(8):262. doi: 10.1136/vr.104818. Epub 2018 Jul 20.

PMID:
30030413
27.

Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.

Olivieri I, Accorinti M, Abicca I, Bisceglia P, Cimino L, Latanza L, Leccese P, Lubrano E, Marchesoni A, Miserocchi E, Neri P, Salvarani C, Scarpa R, D'Angelo S; CORE Study Group.

Rheumatol Int. 2018 Sep;38(9):1727-1734. doi: 10.1007/s00296-018-4094-1. Epub 2018 Jun 30.

PMID:
29961101
28.

Clinical Outcomes of Preloaded Descemet Membrane Endothelial Keratoplasty Grafts With Endothelium Tri-Folded Inwards.

Busin M, Leon P, D'Angelo S, Ruzza A, Ferrari S, Ponzin D, Parekh M.

Am J Ophthalmol. 2018 Sep;193:106-113. doi: 10.1016/j.ajo.2018.06.013. Epub 2018 Jun 27.

PMID:
29940169
29.

Current treatment options for psoriatic arthritis: spotlight on abatacept.

Ursini F, Russo E, De Giorgio R, De Sarro G, D'Angelo S.

Ther Clin Risk Manag. 2018 Jun 6;14:1053-1059. doi: 10.2147/TCRM.S148586. eCollection 2018. Review.

30.

Metformin and Autoimmunity: A "New Deal" of an Old Drug.

Ursini F, Russo E, Pellino G, D'Angelo S, Chiaravalloti A, De Sarro G, Manfredini R, De Giorgio R.

Front Immunol. 2018 Jun 4;9:1236. doi: 10.3389/fimmu.2018.01236. eCollection 2018. Review.

31.

Physician's Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study.

Cauli A, Gladman DD, Mathieu A, Olivieri I, Porru G, Tak PP, Sardu C, Scarpa R, Marchesoni A, Taylor WJ, Salvarani C, Kalden J, Lubrano E, Carneiro S, Piga M, Floris A, Desiati F, Flynn JA, D'Angelo S, van Kuijk AWR, Catanoso MG, Caso F, Contu P, Ujfalussy I, Helliwell PS, Mease PJ; GRAPPA 3PPsA Study Group.

J Rheumatol. 2018 Aug;45(9):1256-1262. doi: 10.3899/jrheum.171183. Epub 2018 Jun 15.

PMID:
29907666
32.

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma.

D'Angelo SP, Melchiori L, Merchant MS, Bernstein D, Glod J, Kaplan R, Grupp S, Tap WD, Chagin K, Binder GK, Basu S, Lowther DE, Wang R, Bath N, Tipping A, Betts G, Ramachandran I, Navenot JM, Zhang H, Wells DK, Van Winkle E, Kari G, Trivedi T, Holdich T, Pandite L, Amado R, Mackall CL.

Cancer Discov. 2018 Aug;8(8):944-957. doi: 10.1158/2159-8290.CD-17-1417. Epub 2018 Jun 11.

PMID:
29891538
33.

Rapid purification of billions of circulating CD19+ B cells directly from leukophoresis samples.

Ferrara F, Kolnik M, D'Angelo S, Erasmus FM, Vorholt D, Bradbury ARM.

N Biotechnol. 2018 Nov 25;46:14-21. doi: 10.1016/j.nbt.2018.05.006. Epub 2018 Jun 2.

PMID:
29870785
34.

Selection of phage-displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications.

D'Angelo S, Staquicini FI, Ferrara F, Staquicini DI, Sharma G, Tarleton CA, Nguyen H, Naranjo LA, Sidman RL, Arap W, Bradbury AR, Pasqualini R.

JCI Insight. 2018 May 3;3(9). pii: 98305. doi: 10.1172/jci.insight.98305.

35.

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.

Hrdinová J, D'Angelo S, Graça NAG, Ercig B, Vanhoorelbeke K, Veyradier A, Voorberg J, Coppo P.

Haematologica. 2018 Jul;103(7):1099-1109. doi: 10.3324/haematol.2016.151407. Epub 2018 Apr 19. Review.

36.

ERAP1 molecular characterization: Identification of a de novo allelic variant.

Padula MC, Leccese P, Padula AA, D'Angelo S, Martelli G.

HLA. 2018 Mar 26. doi: 10.1111/tan.13262. [Epub ahead of print]

PMID:
29577660
37.

Many Routes to an Antibody Heavy-Chain CDR3: Necessary, Yet Insufficient, for Specific Binding.

D'Angelo S, Ferrara F, Naranjo L, Erasmus MF, Hraber P, Bradbury ARM.

Front Immunol. 2018 Mar 8;9:395. doi: 10.3389/fimmu.2018.00395. eCollection 2018.

38.

Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma: A Preplanned Interim Analysis of a Clinical Trial.

D'Angelo SP, Russell J, Lebbé C, Chmielowski B, Gambichler T, Grob JJ, Kiecker F, Rabinowits G, Terheyden P, Zwiener I, Bajars M, Hennessy M, Kaufman HL.

JAMA Oncol. 2018 Sep 1;4(9):e180077. doi: 10.1001/jamaoncol.2018.0077. Epub 2018 Sep 13.

39.

Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease.

Rizzello F, Olivieri I, Armuzzi A, Ayala F, Bettoli V, Bianchi L, Cimino L, Costanzo A, Cristaudo A, D'Angelo S, Daperno M, Fostini AC, Galeazzi M, Gilio M, Gionchetti P, Gisondi P, Lubrano E, Marchesoni A, Offidani A, Orlando A, Pugliese D, Salvarani C, Scarpa R, Vecchi M, Girolomoni G.

Adv Ther. 2018 Apr;35(4):545-562. doi: 10.1007/s12325-018-0672-6. Epub 2018 Mar 7.

40.

Is the recent increment in attributable deaths to type-2 diabetes (T2D) associated with the latest chikungunya outbreak in a major epidemic area in Brazil?

Cavalcanti LPG, D'angelo SM, Lemos DRQ, Barreto FKA, Siqueira AM, Miyajima F.

Rev Soc Bras Med Trop. 2018 Jan-Feb;51(1):63-65. doi: 10.1590/0037-8682-0440-2017.

41.

Safety of treatment options for spondyloarthritis: a narrative review.

D'Angelo S, Carriero A, Gilio M, Ursini F, Leccese P, Palazzi C.

Expert Opin Drug Saf. 2018 May;17(5):475-486. doi: 10.1080/14740338.2018.1448785. Epub 2018 Mar 14. Review.

PMID:
29505325
42.

Prior fragility fracture and risk of incident ischaemic cardiovascular events: results from UK Biobank.

Paccou J, D'Angelo S, Rhodes A, Curtis EM, Raisi-Estabragh Z, Edwards M, Walker-Bone K, Cooper C, Petersen SE, Harvey NC.

Osteoporos Int. 2018 Jun;29(6):1321-1328. doi: 10.1007/s00198-018-4426-8. Epub 2018 Feb 26.

43.

A step towards standardization: A method for end-point titer determination by fluorescence index of an automated microscope. End-point titer determination by fluorescence index.

Carbone T, Gilio M, Padula MC, Tramontano G, D'Angelo S, Pafundi V.

J Immunol Methods. 2018 May;456:67-71. doi: 10.1016/j.jim.2018.02.014. Epub 2018 Feb 19.

PMID:
29470974
44.

Primer Design and Inverse PCR on Yeast Display Antibody Selection Outputs.

Ferrara F, Bradbury ARM, D'Angelo S.

Methods Mol Biol. 2018;1721:35-45. doi: 10.1007/978-1-4939-7546-4_4. Review.

PMID:
29423845
45.

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis.

Lubrano E, Perrotta FM, Manara M, D'Angelo S, Addimanda O, Ramonda R, Punzi L, Olivieri I, Salvarani C, Marchesoni A.

J Rheumatol. 2018 Feb;45(2):195-201. doi: 10.3899/jrheum.170666.

PMID:
29419448
46.

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.

D'Angelo SP, Mahoney MR, Van Tine BA, Atkins J, Milhem MM, Jahagirdar BN, Antonescu CR, Horvath E, Tap WD, Schwartz GK, Streicher H.

Lancet Oncol. 2018 Mar;19(3):416-426. doi: 10.1016/S1470-2045(18)30006-8. Epub 2018 Jan 19.

47.

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.

Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P.

J Immunother Cancer. 2018 Jan 19;6(1):7. doi: 10.1186/s40425-017-0310-x.

48.

Calcium and Vitamin D Supplementation Are Not Associated With Risk of Incident Ischemic Cardiac Events or Death: Findings From the UK Biobank Cohort.

Harvey NC, D'Angelo S, Paccou J, Curtis EM, Edwards M, Raisi-Estabragh Z, Walker-Bone K, Petersen SE, Cooper C.

J Bone Miner Res. 2018 May;33(5):803-811. doi: 10.1002/jbmr.3375. Epub 2018 Feb 8.

49.

Cytokine release syndrome after radiation therapy: case report and review of the literature.

Barker CA, Kim SK, Budhu S, Matsoukas K, Daniyan AF, D'Angelo SP.

J Immunother Cancer. 2018 Jan 3;6(1):1. doi: 10.1186/s40425-017-0311-9.

50.

Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial.

Chung DJ, Carvajal RD, Postow MA, Sharma S, Pronschinske KB, Shyer JA, Singh-Kandah S, Dickson MA, D'Angelo SP, Wolchok JD, Young JW.

Oncoimmunology. 2017 Sep 21;7(1):e1372081. doi: 10.1080/2162402X.2017.1372081. eCollection 2017.

Supplemental Content

Loading ...
Support Center